Understanding the impact of pathophysiological alterations during critical illness on drug pharmacokinetics

Jamal JA 1 , Roger C 2 , Roberts JA 3

Affiliations 

  • 1 Department of Pharmacy, Hospital Tengku Ampuan Afzan, 25100 Kuantan, Pahang, Malaysia
  • 2 Department of Anaesthesiology, Emergency and Critical Care Medicine, Intensive Care Unit, Nîmes University Hospital, place du Professeur Debré, 30029 Nîmes, France
  • 3 University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia; Centre for Translational Anti-Infective Pharmacodynamics, School of Pharmacy, The University of Queensland, Brisbane, Australia; Departments of Pharmacy and Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, Australia. Electronic address: j.roberts2@uq.edu.au
Anaesth Crit Care Pain Med, 2018 12;37(6):515-517.
PMID: 30359771 DOI: 10.1016/j.accpm.2018.10.006

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications